GCIA
FLACU

Gabelli & Co Investment Advisers’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio FLACU Stock Details FLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,200
Closed -$104K – 433
2022
Q3 		$104K Hold
10,200
– – 0.01% 337
2022
Q2 		$101K Hold
10,200
– – 0.01% 356
2022
Q1 		$102K Hold
10,200
– – 0.01% 375
2021
Q4 		$101K Hold
10,200
– – 0.01% 381
2021
Q3 		$102K Hold
10,200
– – 0.01% 373
2021
Q2 		$103K Hold
10,200
– – 0.01% 369
2021
Q1 		$104K Hold
10,200
– – 0.01% 369
2020
Q4 		$106K Buy
+10,200
New +$106K 0.02% 283

Gabelli & Co Investment Advisers's FLACU Position: Q4 2022 in Review

Gabelli & Co Investment Advisers sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q4 2022, closing a stake of 10,200 shares — an estimated $104K sold.

Gabelli & Co Investment Advisers first reported a position in FLACU in Q4 2020 and held it in 8 quarters. The position peaked at $106K in Q4 2020. 0 funds tracked by Wall St. Rank hold FLACU as of Q4 2022.

  • Gabelli & Co Investment Advisers reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q4 2022 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 10,200 Frazier Lifesciences Acquisition Corporation Unit shares in Q4 2022, an estimated $104K.
  • Gabelli & Co Investment Advisers first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 8 quarters.
  • Gabelli & Co Investment Advisers's Frazier Lifesciences Acquisition Corporation Unit position peaked at $106K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q4 2022.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2022, filed 13 Feb 2023.